Research Article

Translational Bioinformatics and Multi-Omics Integration for AI-Driven Biomarker Discovery in Precision Oncology

Volume: 10 Number: 1 June 30, 2026
EN

Translational Bioinformatics and Multi-Omics Integration for AI-Driven Biomarker Discovery in Precision Oncology

Abstract

This review provides a comprehensive overview of recent advances in cancer biomarker discovery through multi-omics data integration combined with artificial intelligence (AI), highlighting how these approaches facilitate early diagnosis, improve prognostic accuracy, and enable personalized treatment in precision oncology. We conducted a literature review of high-throughput technologies, including genomics, transcriptomics, proteomics, and metabolomics, with particular emphasis on integrative computational strategies, such as translational bioinformatics, AI, and emerging quantum machine learning (QML), that support multidimensional data analysis for biomarker identification. Integrative analyses of multi-omics datasets using advanced computational methods have expanded our understanding of tumor molecular heterogeneity and complexity. Novel approaches, including liquid biopsy, digital pathology, and artificial intelligence-assisted image analysis, enhance early detection, therapy monitoring, and individualized interventions. Despite these advances, data standardization, harmonization of heterogeneous datasets, reproducibility, and ethical considerations remain challenges that must be addressed to enable effective clinical translation. Nevertheless, the integration of multi-omics data with AI and advanced computational methods is transforming cancer biomarker discovery, bridging molecular complexity with actionable clinical insights, and improving early detection, precise patient stratification, and therapy monitoring. Future progress will depend on interdisciplinary collaboration, global data harmonization, and continued technological innovation. Collectively, these advances pave the way toward truly personalized, proactive cancer care and position oncology as a data-driven discipline with improved patient outcomes.

Keywords

References

  1. Abbas, A., Sutter, D., Zoufal, C., Lucchi, A., Figalli, A., and Woerner, S. (2021). Power of quantum neural networks Nature Computational Science, 1(6), 403-409. https://doi.org/10.1038/s43588-021-00084-1 google scholar
  2. Akhoundova, D., & Rubin, M. A. (2022). Clinical application of advanced multi-omics tumor profiling: Shaping the future of precision oncology Cancer Cell, 40(9), 920-938. DOI: 10.1016/j.ccell.2022.08.011 google scholar
  3. Al-Daffaie, F. M., Al-Mudhafar, S. F., Alhomsi, A., Tarazi, H., Almehdi, A. M., El-Huneidi, W., Abu-Gharbieh, E., Bustanji, Y., Alqudah, M. A. Y., Abuhelwa, A. Y., Guella, A., Alzoubi, K. H., & Semreen, M. H. (2024). Metabolomics and proteomics in prostate cancer research: Overview, analytical techniques, data analysis, and recent clinical applications International Journal of Molecular Sciences, vol. 25, no. 10, 5071. google scholar
  4. Arango-Argoty, G., Bikiel, D. E., Sun, G. J., Kipkogei, E., Smith, K. M., Carrasco Pro, S., Choe, E. Y., & Jacob, E. (2025). AI-driven predictive biomarker discovery with contrastive learning to improve clinical trial outcomes. Journal of Clinical Oncology and Pharmacology. Cancer Cell, 43(5), 875-890.e878. https://doi.org/10.1016/j.ccell.2025.03.029https://doi.org/10.1016/j.ccell.2025.03.029 google scholar
  5. Beam, A. L., & Kohane, I. S. (2018). Big Data and Machine Learning in Health Care. JAMA, 319(13), 1317-1318. DOI: 10.1001/jama.2017.18391 google scholar
  6. Bersanelli, M., Mosca, E., Remondini, D., Giampieri, E., Sala, C., Castellani, G., and Milanesi, L. (2016). Methods for the integration of multi-omics data: mathematical aspects. BMC Bioinformatics, 17 Suppl 2(Suppl 2), 15. https://doi.org/10.1186/s12859-015-0857-9 google scholar
  7. Bjartell, A., Krzyzanowska, A., Liu, V. Y. T., Tierney, M., Royce, T. J., Sjöström, M., Palominos-Rivera, M. M., Chen, E., Kraft, A., Esteva, A., and Feng, F. Y. (2025). Validation of a Digital Pathology–Based Multimodal Artificial Intelligence Biomarker in a Prostatectomy-Treated Prospective, Real-World Prostate Cancer Cohort Clinical Cancer Research, 31(8), 1546-1553. DOI: 10.1158/1078-0432.Ccr-24-3656 google scholar
  8. Bozkurt, S., Cahan, E. M., Seneviratne, M. G., Sun, R., Lossio-Ventura, J. A., Ioannidis, J. P. A., and Hernandez-Boussard, T. (2020). Demographic data and representativeness in machine learning models using electronic health records Journal of the American Medical Informatics Association, 27(12), 1878-1884. https://doi.org/10.1093/jamia/ocaa164 google scholar

Details

Primary Language

English

Subjects

Genomics and Transcriptomics, Proteomics and Metabolomics, Translational and Applied Bioinformatics

Journal Section

Research Article

Publication Date

June 30, 2026

Submission Date

October 8, 2025

Acceptance Date

January 6, 2026

Published in Issue

Year 2026 Volume: 10 Number: 1

APA
Kara, K., & Gunel, T. (2026). Translational Bioinformatics and Multi-Omics Integration for AI-Driven Biomarker Discovery in Precision Oncology. Acta Infologica, 10(1), 1-20. https://doi.org/10.26650/acin.1799569
AMA
1.Kara K, Gunel T. Translational Bioinformatics and Multi-Omics Integration for AI-Driven Biomarker Discovery in Precision Oncology. ACIN. 2026;10(1):1-20. doi:10.26650/acin.1799569
Chicago
Kara, Kaan, and Tuba Gunel. 2026. “Translational Bioinformatics and Multi-Omics Integration for AI-Driven Biomarker Discovery in Precision Oncology”. Acta Infologica 10 (1): 1-20. https://doi.org/10.26650/acin.1799569.
EndNote
Kara K, Gunel T (June 1, 2026) Translational Bioinformatics and Multi-Omics Integration for AI-Driven Biomarker Discovery in Precision Oncology. Acta Infologica 10 1 1–20.
IEEE
[1]K. Kara and T. Gunel, “Translational Bioinformatics and Multi-Omics Integration for AI-Driven Biomarker Discovery in Precision Oncology”, ACIN, vol. 10, no. 1, pp. 1–20, June 2026, doi: 10.26650/acin.1799569.
ISNAD
Kara, Kaan - Gunel, Tuba. “Translational Bioinformatics and Multi-Omics Integration for AI-Driven Biomarker Discovery in Precision Oncology”. Acta Infologica 10/1 (June 1, 2026): 1-20. https://doi.org/10.26650/acin.1799569.
JAMA
1.Kara K, Gunel T. Translational Bioinformatics and Multi-Omics Integration for AI-Driven Biomarker Discovery in Precision Oncology. ACIN. 2026;10:1–20.
MLA
Kara, Kaan, and Tuba Gunel. “Translational Bioinformatics and Multi-Omics Integration for AI-Driven Biomarker Discovery in Precision Oncology”. Acta Infologica, vol. 10, no. 1, June 2026, pp. 1-20, doi:10.26650/acin.1799569.
Vancouver
1.Kaan Kara, Tuba Gunel. Translational Bioinformatics and Multi-Omics Integration for AI-Driven Biomarker Discovery in Precision Oncology. ACIN. 2026 Jun. 1;10(1):1-20. doi:10.26650/acin.1799569